H3HP-DO3A is a tricarboxylic acid derived from 1,4,7,10-tetraazacyclododecane, featuring three carboxymethyl groups and a hydroxypropyl substituent. It serves as a chelating agent intermediate primarily used in the manufacturing of MRI contrast agents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-Bromo-5-(4-methylbenzene-1-sulfonyl)-5H-pyrrolo[2,3-b]pyrazine
pharmaceutical intermediate
1,1-Dimethylethyl N-(5-((4-methylphenyl)sulfonyl)-5H-pyrrolo(2,3-b)pyrazin-2-yl)carbamate
pharmaceutical intermediate
(R)-1-(3-Chlorophenyl)ethanol
pharmaceutical intermediate
Ixazomib Impurity 1
pharmaceutical intermediate
Gadoteridol
pharmaceutical raw material
Calteridol calcium
pharmaceutical raw material
Tetraxetan
pharmaceutical raw material
Dotam-mono acid
research compound
2-[4,7-bis(carboxymethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
IQUHNCOJRJBMSU-UHFFFAOYSA-N
CC(CN1CCN(CCN(CCN(CC1)CC(=O)O)CC(=O)O)CC(=O)O)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.